Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Credit Suisse 27th Annual Healthcare Conference 2018
24 slides from Phibro Animal Health's conference presentation, Nov 13, 2018
Slide 1: Phibro Animal Health Corporation 27th Annual Healthcare Conference
Phibro Animal Health Corporation 27th Annual Healthcare Conference November 13, 2018
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements d
Slide 3: A Global Leader in Animal Health
Phibro Animal Health Corporation A Global Leader in Animal Health Dedicated to supporting Products and solutions Global animal health the growing worldwide enhance health, nutrition company focused on demand for animal and productivity of food animals protein animals >1,500 product $827 million Manu
Slide 4: Core Competencies
Core Competencies Effective Solutions Medicated Feed Vaccines Nutritional MVP Adjuvants Mineral Ethanol Additives • Poultry Specialties Nutrition Performance • Antibiotics • Swine • Immune modulators • Trace and macro • Antimicrobials • Anticoccidials • Bovine • Anionic supplement Minerals • Cleanin
Slide 5: The Factors Driving Demand for Our Products
The Factors Driving Demand for Our Products Phibro Sees a Bright Outlook Global wealth and population growth drives animal protein demand Limited additional land and water for agriculture Innovation Food supply becoming global is the Solution Consumer demand for safe, affordable food Responsible ani
Slide 6: The Evolution of Phibro
The Evolution of Phibro Acquisitions Complement Strong Organic Growth 6 November 13, 2018 Credit Suisse Healthcare Conference
Slide 7: The Evolution of Phibro
The Evolution of Phibro Acquisitions Complement Strong Organic Growth 7 November 13, 2018 Credit Suisse Healthcare Conference
Slide 8: Our Company
Our Company $827 Net Sales $129 Adjusted EBITDA Mineral Nutrition Animal Health Performance Products $238 net sales $534 net sales $55 net sales $17 Adjusted EBITDA $144 Adjusted EBITDA $2 Adjusted EBITDA Poultry, swine, dairy, cattle, Trace minerals for animals Specialty chemicals aquaculture Medic
Slide 9: Net Sales and Adjusted EBITDA
Net Sales and Adjusted EBITDA Net Sales 820 4% CAGR 752 764 53 749 692 51 49 48 59 235 Adjusted EBITDA 4% CAGR 9% CAGR 217 218 129 227 202 120 110 102 114 91 102 532 5% CAGR 471 486 498 431 15.7% 15.7% 15.2% 13.8% 2014 2015 2016 2017 2018 13.1% Animal Health Mineral Nutrition Performance Products 20
Slide 10: Net Sales
Net Sales $820 million Species Regions Mineral Nutrition(1) Other 17% United States & United States & Poultry 39% Canada $235 Canada $221 Swine 12% U.S. $53 Latin America Cattle 10% Performance $121 Products(2) Europe, Dairy 22% Middle East & Africa $121 Asia Pacific $69 Animal Health $532 Net sales
Slide 11: Animal Health Business Segment
Animal Health Business Segment
Slide 12: Animal Health Highlights
Animal Health Highlights Record of strong revenue Products drive value Highly diversified growth and margin creation for customers customer base expansion International expansion 59% of animal health Deploying additional field Southeast Asia sales are international force to drive growth South Americ
Slide 13: Animal Health Segment
Animal Health Segment Net Sales Adjusted EBITDA 142 9% CAGR 532 5% CAGR 130 127 486 498 120 471 72 15% CAGR 431 52 65 45 100 112 41 123 18% CAGR 82 94 111 63 26.7% 1% CAGR 26.2% 26.2% 327 336 340 322 337 24.3% 23.3% 2014 2015 2016 2017 2018 2014 2015 2016 2017 2018 MFA's and Other Nutritional Specia
Slide 14: Nutritional Specialties
Nutritional Specialties Key Products OmniGen-AF® Solutions for changing customer needs Description Propriety formula of all natural ingredients Products help improve health and performance Immune enhancer for dairy cows Fed to >20% of U.S. and Canada dairy cows(1) Focus on dairy and poultry Benefits
Slide 15: Vaccines
Vaccines Key Products TAbic ® Poultry, swine and bovine vaccines Description Technology for formulation / delivery of vaccines Effervescent tablets in sterile blister packs Replaces glass bottles Benefits Provides superior convenience and logistical benefits over conventional glass bottles Product P
Slide 16: Medicated Feed Additives (MFAs)
Medicated Feed Additives (MFAs) Key Products Virginiamycin Antimicrobials Description Remedy for range of bacterial infections and enteric diseases Effective in multiple species, including poultry, swine and cattle Benefits Allows producers to maintain healthy animals Anticoccidials Humane managemen
Slide 17: Mineral Nutrition Segment
Mineral Nutrition Segment Phibro
Slide 18: Mineral Nutrition Segment
Mineral Nutrition Segment Key Products Trace and macro mineral products including copper, zinc, Net Sales 235 4% CAGR cobalt, iron, selenium, manganese, magnesium, iodine, 227 others 217 218 Organic trace minerals 202 Fortifies and maintains an optimal balance of minerals in the diet 2014 2015 2016
Slide 19: Guidance for the June 2019 Year
Guidance for the June 2019 Year
Slide 20: Guidance for the June 2019 Year
Guidance for the June 2019 Year Phibro Animal Health Corporation Guidance for fiscal year 2019 For the year ending June 30 2019 2018 Change from 2018 (in millions, except per share amounts and percentages) Net sales - Animal Health segment $ 550 - $ 565 $ 532 $ 18 - $ 33 3% - 6% Net sales $ 850 - $
Slide 21: Guidance for the June 2019 Year
Guidance for the June 2019 Year Updated annual expected effective income tax rate to 28.0% - 28.5% - Increase of 1.0 - 1.5 percentage points over previous guidance - Expected to be subject to GILTI provisions of the new U.S. Tax Act, related to allocation of domestic interest expense and certain oth
Slide 22: Guidance for the June 2019 Year
Guidance for the June 2019 Year We expect SG&A to increase as we make strategic investments to develop future growth, including - New development, additional registrations and increased volumes of existing nutritional specialties and vaccines technologies, including expansion into new geographic mar
Slide 23: Phibro's Strengths
Phibro’s Strengths Summary Products aligned with Products economically Global presence and need for increased important to our leading positions in high protein production customers’ success growth markets Diversified and Promote animal health Experienced sales and complementary product and welfare
Slide 24: Trademarks and copyright notice
© 2018 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; AB20; Animate; Aviax; Cellerate Yeast Solutions; Gemstone; Lactrol; Magni-Phi; Mecadox; MJPRRS; Neo-Terra; Neo- Terramycin; Neo-TM; Nicarb; OmniGen-AF; PAQ-Gro; Stafa
Phibro Animal Health — Credit Suisse 27th Annual Healthcare Conference 2018 on 6ix